Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 84.85 USD 0.84% Market Closed
Market Cap: 4.2B USD
Have any thoughts about
Prestige Consumer Healthcare Inc?
Write Note

Wall Street
Price Targets

PBH Price Targets Summary
Prestige Consumer Healthcare Inc

Wall Street analysts forecast PBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBH is 89.59 USD with a low forecast of 81.81 USD and a high forecast of 99.75 USD.

Lowest
Price Target
81.81 USD
4% Downside
Average
Price Target
89.59 USD
6% Upside
Highest
Price Target
99.75 USD
18% Upside

PBH Last Price Targets
Prestige Consumer Healthcare Inc

The latest public price target was made on Nov 5, 2024 by Susan Anderson from Canaccord Genuity , who expects PBH stock to rise by 1% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Susan Anderson
Canaccord Genuity
86 USD
Upside 1%
2 weeks ago
Nov 5, 2024
Presitge Brands (PBH) PT Raised to $86 at Canaccord Genuity
StreetInsider
Linda Bolton Weiser
D.A. Davidson
93 USD
Upside 10%
5 months ago
Jun 21, 2024
DA Davidson Defending Presitge Brands (PBH), Uprades to Buy
StreetInsider
Susan Anderson
Canaccord Genuity
Price Target 86 USD
Upside/Downside 1%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 93 USD
Upside/Downside 10%
View Source
Prestige Consumer Healthcare Inc Competitors:
Price Targets
IPN
Ipsen SA
18% Upside
300725
PharmaBlock Sciences Nanjing Inc
19% Upside
LLY
Eli Lilly and Co
36% Upside
605507
Guobang Pharma Ltd
15% Upside
TBPH
Theravance Biopharma Inc
42% Upside
214370
Caregen Co Ltd
36% Downside
EMCURE
Emcure Pharmaceuticals Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's revenue is 4%. The projected CAGR for the next 3 years is 2%.

4%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's operating income is 3%. The projected CAGR for the next 3 years is 3%.

3%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's net income is 10%. The projected CAGR for the next 3 years is 5%.

10%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PBH's stock price target?
Price Target
89.59 USD

According to Wall Street analysts, the average 1-year price target for PBH is 89.59 USD with a low forecast of 81.81 USD and a high forecast of 99.75 USD.

What is Prestige Consumer Healthcare Inc's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's revenue is 4%. The projected CAGR for the next 3 years is 2%.

What is Prestige Consumer Healthcare Inc's Operating Income forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's operating income is 3%. The projected CAGR for the next 3 years is 3%.

What is Prestige Consumer Healthcare Inc's Net Income forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's net income is 10%. The projected CAGR for the next 3 years is 5%.

Back to Top